Pregabalin
Linefor belongs to a group of medicines used to treat epilepsy, neuropathic pain, and generalized anxiety disorder (GAD) in adults.
Linefor is used to treat long-term pain caused by nerve damage. Many different diseases, such as diabetes or shingles, can cause peripheral neuropathic pain. The pain can be described as a feeling of heat, burning, pulsating, shooting, stabbing, as sharp pain, cramps, soreness, tingling, or numbness. Peripheral and central neuropathic pain can also be associated with mood changes, sleep disturbances, fatigue, which can affect the patient's physical and social functioning and overall quality of life.
Linefor is used to treat certain types of epilepsy (partial seizures, which are or are not secondarily generalized) in adults. The doctor may prescribe Linefor if the current treatment is not fully effective. Linefor is given as an add-on therapy to the current treatment. Linefor should not be used alone, but always in combination with other antiepileptic medicines.
Linefor is used to treat generalized anxiety disorder (GAD). The symptoms of GAD include prolonged, excessive anxiety and worry that are difficult to control. GAD can also cause restlessness, nervousness, or feeling on edge, easy fatigability, difficulty concentrating or feeling of emptiness in the head, irritability, increased muscle tension, or sleep disturbances. The symptoms are different from the stresses and tensions of everyday life.
Before starting to take Linefor, the patient should discuss it with their doctor or pharmacist.
Dependence
Some people may become dependent on Linefor (need to continue taking the medicine). After stopping Linefor, withdrawal symptoms may occur (see section 3 "How to take Linefor" and "Stopping Linefor"). If the patient is concerned that they may become dependent on Linefor, they should discuss it with their doctor.
If the patient experiences any of the following symptoms while taking Linefor, it may indicate dependence:
The safety and efficacy of Linefor in children and adolescents (under 18 years of age) have not been established, so pregabalin should not be used in this age group.
The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
Linefor and some medicines may interact with each other (interactions). When taken with other medicines with a sedating effect (e.g., opioids), Linefor may enhance these effects and cause respiratory failure, coma, and death. The degree of dizziness, somnolence, and decreased concentration may increase if Linefor is taken with medicines containing:
Linefor can be taken with oral contraceptives.
Linefor capsules can be taken with or without food.
The patient should not drink alcohol while taking Linefor.
Linefor should not be taken during pregnancy or breastfeeding, unless the doctor decides otherwise. Taking pregabalin during the first 3 months of pregnancy may cause birth defects in the unborn child. A study in Scandinavian countries analyzed data from women who took pregabalin during the first 3 months of pregnancy and found birth defects in 6 out of every 100 babies born, while in women who were not treated with pregabalin, birth defects occurred in 4 out of every 100 babies born. The reported birth defects involved the face (cleft lip and palate), eyes, nervous system (including the brain), kidneys, and genital organs.
Women of childbearing age should use effective contraception. If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a baby, they should consult their doctor or pharmacist before taking this medicine.
Linefor may cause dizziness, somnolence, and decreased concentration. The patient should not drive, operate complex machines, or perform other potentially hazardous activities until they have determined the effect of the medicine on their ability to perform these activities.
If the patient has been diagnosed with intolerance to some sugars, they should consult their doctor before taking the medicine.
This medicine should always be taken exactly as prescribed by the doctor. In case of doubts, the patient should consult their doctor or pharmacist. The patient should not take more of the medicine than prescribed.
The doctor will determine the dose of the medicine that is most suitable for the patient.
Linefor is intended for oral use only.
If the patient feels that Linefor is too strong or too weak, they should inform their doctor or pharmacist.
Patient over 65 years of age should take Linefor according to the presented scheme, unless they have kidney disease.
In patients with impaired renal function, the doctor may decide on a different dosing schedule and/or change the dose of the medicine.
The capsule should be swallowed whole and washed down with water.
Linefor should be taken for as long as the doctor has prescribed. The treatment can only be stopped on the doctor's advice.
The patient should inform their doctor or immediately go to the nearest hospital emergency department. The patient should take the packaging of Linefor with them. After taking a higher dose of Linefor than prescribed, the patient may feel sleepy, confused, excited, or restless. There have also been reports of seizures and loss of consciousness (coma).
It is important to take Linefor regularly at the same times every day. If a dose is missed, the patient should take it as soon as possible, unless it is almost time for the next dose. In this case, the patient should continue the treatment according to the prescribed schedule. The patient should not take a double dose to make up for the missed dose.
The patient should not stop taking Linefor suddenly. If the patient wants to stop taking Linefor, they should first discuss it with their doctor. The doctor will inform them how to do it. If the treatment needs to be stopped, it should be done gradually over at least one week.
The patient should be aware that after stopping short-term or long-term treatment with Linefor, certain side effects may occur, known as withdrawal symptoms (see section "Stopping Linefor"). These symptoms include sleep disturbances, headache, nausea, feeling of anxiety, diarrhea, flu-like symptoms, seizures, nervousness, depression, thoughts of self-harm or suicide, pain, excessive sweating, and dizziness. These symptoms may be more frequent or severe if the patient has taken Linefor for a longer period. If withdrawal symptoms occur, the patient should contact their doctor.
In case of any further doubts about taking this medicine, the patient should consult their doctor or pharmacist.
Like all medicines, Linefor can cause side effects, although not everybody gets them.
Some side effects, such as somnolence, may occur more frequently because patients with spinal cord injury may also take other medicines, such as painkillers or muscle relaxants, which have similar side effects to Linefor, and the intensity of these effects may be greater when such medicines are taken at the same time.
Blurred vision, double vision
The patient should be aware that after stopping short-term or long-term treatment with Linefor, certain side effects may occur, known as withdrawal symptoms (see section "Stopping Linefor").
After the medicine was placed on the market, the following side effects were also reported: breathing difficulties, shallow breathing.
If the patient experiences any side effects, including any side effects not listed in this leaflet, they should tell their doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
The medicine should not be taken after the expiry date stated on the carton after EXP.
The expiry date refers to the last day of the month stated.
The inscription on the packaging after the abbreviation EXP indicates the expiry date, and after the abbreviation Lot/LOT, it indicates the batch number.
There are no special precautions for storing the medicine.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
25 mg capsules
White, hard gelatin capsules with the inscription "25" on the capsule body.
Capsule size 4.
50 mg capsules
White, hard gelatin capsules with the inscription "50" on the capsule body.
Capsule size 3.
75 mg capsules
Hard gelatin capsules with a white body and the inscription "75" and a red-brown cap. Capsule size 3.
100 mg capsules Red-brown, hard gelatin capsules with the inscription "100" on the capsule body.
Capsule size 1.
150 mg capsules White, hard gelatin capsules with the inscription "150" on the capsule body.
Capsule size 1.
200 mg capsules Light brown, hard gelatin capsules with the inscription "200" on the capsule body.
Capsule size 0.
Hard gelatin capsules with a white body and the inscription "225" and a light brown cap. Capsule size 0.
225 mg capsules
Hard gelatin capsules with a white body and the inscription "300" and a red-brown cap. Capsule size 0.
300 mg capsules
Linefor 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, and 300 mg hard capsules are packaged in aluminum/PVC/PVDC blisters in a cardboard box.
Linefor is available in packages of 14, 21, 56, 60, or 84 hard capsules.
Linefor 75 mg and 150 mg are also available in packages of 28 hard capsules.
Not all pack sizes may be marketed.
Pharmaceutical Works POLPHARMA S.A.
Pelplińska 19, 83-200 Starogard Gdański
phone: +48 22 364 61 01
Bulgaria: Линефор 50 mg, 75 mg, 150 mg твърди капсули
Netherlands: Linefor 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, 300 mg harde capsules
Lithuania: Linefor 75 mg kietosios kapsulės
Latvia: Linefor 75 mg cietās kapsulas
Poland: Linefor, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, 300 mg, kapsułki, twarde
Date of last revision of the leaflet:April 2024
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.